Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 4/20 | 0.73 |
| ▸ | ESR1 | P03372 | 2/20 | 0.63 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.63 |
| ▸ | TACR2 | P21452 | 2/20 | 0.63 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.63 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.63 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | SHBG | P04278 | 1/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.63 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.63 |
| ▸ | HTR2C | P28335 | 1/20 | 0.63 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.63 |
| ▸ | TST | Q16762 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27946204 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL5271597 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL28265190 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL3261675 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL811576 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL361374 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL5834756 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL28816241 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL11959874 | 1.00 | KCNH2 (0.73) | KCNH2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL2056149 | 0.98 | KCNH2 (0.70) | KCNH2ESR1ADRA2AADORA3TACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119816509-A | Novel iron-based compounds, method for the production thereof and use thereof as catalysts | 巴黎萨克雷大学 | 2025-04-11 | — | — | CN | disclosed |
| CN-119039108-A | Method for preparing 4-n-alkylphenol | 大连奇凯医药科技有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-109096046-B | Preparation method of halogenated alkane synthesized from styrene and derivatives thereof and trichloroalkane | 温州大学 | 2021-03-02 | — | — | CN | disclosed |
| EP-1312605-B1 | Method for producing biaryl compounds | SUMITOMO CHEMICAL CO (JP) | 2007-04-25 | — | — | EP | disclosed |
| US-7122711-B2 | Method for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-10-17 | — | — | US | disclosed |
| US-20030158419-A1 | Method for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-08-21 | — | — | US | disclosed |
| EP-1312605-A1 | Method for producing biaryl compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-05-21 | — | — | EP | disclosed |
| US-4076756-A | Process for the preparation of triarylborane | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-02-28 | — | — | US | disclosed |
| US-4046815-A | Process for the preparation of triarylborane | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-09-06 | — | — | US | disclosed |
| US-4045495-A | Process for the preparation of triarylboranes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030158419-A1 | Method for producing biaryl compound | B2M, BMI1, CYP2W1 | KCNH2 305/4885ESR1 1343/4885ADRA2A 1855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.